- Home
- ADAG
ADAG
Adagene Inc.
as 07-26-2024 4:00pm EST
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
| Founded: | 2011 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 113.9M | IPO Year: | 2021 |
| Target Price: | $5.00 | AVG Volume (30 days): | 12.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $4.38 | Next Earning Date: | 08-29-2024 |
| Revenue: | $18,111,491 | Revenue Growth: | 78.00% |
| Revenue Growth (this year): | -64.33% | Revenue Growth (next year): | 5.26% |
Latest Adagene Inc. News
ADAG Breaking Stock News: Dive into ADAG Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update
GlobeNewswire
15 days ago
Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September
Simply Wall St.
a month ago
Adagene Inc. (NASDAQ:ADAG) most popular amongst private equity firms who own 39% of the shares, institutions hold 30%
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
CNW Group
a month ago
**Canadian Interest in American Whiskey Peaks Ahead of Bourbon Day**
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
Motley Fool
a month ago
Where Will DocuSign Stock Be in 1 Year?
Reuters
a month ago
Spotify to introduce expensive plan later this year, Bloomberg News reports
Compare ADAG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADAG Adagene Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.